Assi - if you couple your take with fact that we have a <$50 m company spinning off a company appraised at $500 m, it's not difficult to think the SEC is doing a deep dive on GNBT. They could suspect GNBT of fraud - Covid vaccines have to be a ripe area right now. Of course, we know that isn't the case, but the SEC may have to verify for themselves that there really is an asset worth $500 m before signing off on the spin out.

In my mind, it's more likely they would be looking at "manipulation" that has held a company with a $500 m asset to $10 m (currently). If that is the case, they might have to make sure nobody internal is in on any "scheme", and maybe they are even looking to find the culprit of the depressed pps. It might be the same group that did the NUGX sale, so this might be a very involved issue that will take a fair amount of time to unwind.

Just my speculation, that's for sure. Happy Thanksgiving, everybody. Have an extra piece of turkey or pie tomorrow, and worry about all this GNBT stuff next week.